Clinical Trial Update: Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of alfuzosin for treating voiding dysfunction in women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Voiding Dysfunction

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Voiding Dysfunction | Phase 2 | Status: COMPLETED